[go: up one dir, main page]

JPH0456807B2 - - Google Patents

Info

Publication number
JPH0456807B2
JPH0456807B2 JP59280689A JP28068984A JPH0456807B2 JP H0456807 B2 JPH0456807 B2 JP H0456807B2 JP 59280689 A JP59280689 A JP 59280689A JP 28068984 A JP28068984 A JP 28068984A JP H0456807 B2 JPH0456807 B2 JP H0456807B2
Authority
JP
Japan
Prior art keywords
group
reaction
physiologically active
agarose
insoluble polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59280689A
Other languages
Japanese (ja)
Other versions
JPS61152634A (en
Inventor
Isatake Matsumoto
Fumihiro Koyama
Seiko Yui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUGYAMA SANGYO KAGAKU KENKYUSHO
Original Assignee
SUGYAMA SANGYO KAGAKU KENKYUSHO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUGYAMA SANGYO KAGAKU KENKYUSHO filed Critical SUGYAMA SANGYO KAGAKU KENKYUSHO
Priority to JP59280689A priority Critical patent/JPS61152634A/en
Publication of JPS61152634A publication Critical patent/JPS61152634A/en
Publication of JPH0456807B2 publication Critical patent/JPH0456807B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

【発明の詳现な説明】[Detailed description of the invention]

〔産業䞊の利甚分野〕 本発明は安定で、か぀、非特異的吞着が少な
く、芪氎性のスペヌサヌを有し、さらに、高いリ
ガンド目的物質ずアフむニテむヌを有する物
質濃床を有する生理掻性物質の補造法に関す
る。 リガンドずしおは、タンパク質、ペプチド、ア
ミノ酞、および生䜓アミン等、すべおのアミノ基
を有する生理掻性物質に適応される。 〔埓来の技術〕 埓来、固定化生理掻性物質を補造するために甚
いられる固定化甚高分子担䜓ずしおは、非特異的
吞着がなく、掻性化されうる官胜基を有するもの
が奜適ずされおいる。 特に、アフむニテむヌ吞着剀ずしお䜿甚する堎
合は、倚孔性で吞着容量を倧きくでき、物理的、
化孊的に安定で、球状成型された高分子担䜓が奜
たしい。このような高分子担䜓ずしおアガロヌス
ゲル、ポリビニルアルコヌル系暹脂等が実甚化さ
れおいる。 〔発明が解決しようずする問題点〕 共有結合による固定化方法ずしお臭化シアンを
甚いる方法がある〔Nature、第215巻、1491〜
1492頁1967幎〕。 この方法は、反応ステツプが短く、容易に調補
できるため、アミノ基、リン酞基の固定化に汎甚
されおいるが、反面、掻性化に䜿甚する臭化シ
アンが有毒である、アミノ基ずカツプリングし
た堎合、架橋郚を圢成しおいるむ゜りレア結合は
䞍安定で、アフむニテむヌクロマトグラフむヌを
行う緩衝液がアルカリ性になるず、固定化された
リガントが挏出しおくる危険性がある、むミド
基のPKaが玄10であるので、䞭性付近においお
は陜電荷をも぀ため、非特異的吞着が起こる、ず
いう欠点を有する。 アミノ基を有する物質を固定化する方法ずし
お、倚糖類の過ペり玠酞酞化法がある
〔Immunology、第20巻、1061〜1065頁1971
幎〕。これは、倚糖類の構成糖残基のゞオヌル構
造を過ペり玠酞酞化し、酞化開裂により生成した
アルデヒド基にアミノ基を反応させ、さらに、氎
玠化ホり玠ナトリりムで還元し、䞍溶性固定化物
質を䜜る方法である。 しかし、この方法では、スペヌサヌリガン
ドず担䜓の間に導入する任意の長さの分子が導
入できない、リガンド濃床が䜎い、ずいうアフ
むニテむヌ吞着䜓ずしおは決定的欠陥を有する。 〔問題点を解決するための手段〕 本発明は、前述の臭化シアン法、倚糖類の過ペ
り玠酞酞化法等の欠点を倧幅に改良したもので、
゚ポキシ基を有する䞍溶性高分子担䜓あるいぱ
ポキシ基を有するスペヌサヌを導入した氎酞基、
アミノ基、カルボキシル基、たたはおよびアミ
ド基を持぀䞍溶性高分子担䜓を、アルカリ性䞋
で、玚氎酞基ず過ペり玠酞酞化により開裂可胜
なゞオヌル基を有する単糖たたは糖ず反応さ
せ、埗られた糖結合䞍溶性高分子を過ペり玠酞に
お酞化開裂するこずにより生ずるアルデヒド基
に、アミノ基を有する生理掻性物質を反応させ、
䞡者の間にシツフ塩基を圢成させお固定化し、さ
らに芁すれば、この反応物を通垞行われおいる氎
玠化ホり玠ナトリりムたたはシアノ氎玠化ホり玠
ナトリりムで還元する方法によ぀お結合を安定化
したものである。 本発明方法においお䜿甚する゚ポキシ基を有す
る䞍溶性高分子ずしおは、予め゚ポキシ基を有す
るあるいは化孊反応によ぀お゚ポキシ基を導入た
氎に䞍溶で安定なポリマヌであればいずれでもよ
い。 ゚ポキシ基を有する䞍溶性高分子担䜓の䟋ずし
おは、ポリグリシゞルメタクリレヌトたたはその
共重合䜓および゚ポキシ暹脂等があり、これらの
担䜓を䜿甚する堎合は、そのたたの状態で反応に
䟛する。たた、氎酞基を有する䞍溶性高分子担䜓
の䟋ずしおは、アガロヌス、ポリビニルアルコヌ
ル系暹脂、ヒドロキシ゚チルたたはメチルア
クリレヌトたたはその共重合䜓、ヒドロキシ゚チ
ルたたはメチルメタクリレヌトたたはその共
重合䜓、−メチロヌルアクリルアミドたたはそ
の共重合䜓等があり、アミノ基を有する䞍溶性高
分子担䜓の䟋ずしおは、アミノ゚チルアガロヌ
ス、アミノヘキシルアガロヌス、アミノ゚チルポ
リアクリルアミド等があり、カルボキシル基を有
する䞍溶性高分子担䜓の䟋ずしおは、マレむン酞
のポリマヌたたはその共重合䜓、アクリル酞のポ
リマヌたたはその共重合䜓、メタクリル酞のポリ
マヌたたはその共重合䜓、むタコン酞のポリマヌ
たたはその共重合䜓等があり、アミド基を有する
䞍溶性高分子担䜓の䟋ずしおは、ポリアクリルア
ミド系ポリマヌ等があるが、これらの担䜓を䜿甚
する堎合は、既知の方法により゚ピクロルヒドリ
ン、゚ピブロムヒドリン等の゚ピハロヒドリンた
たはビスオキシラン化合物を甚いお゚ポキシ基を
導入した埌、反応に䟛するこずが必芁である。 糖結合䞍溶性高分子担䜓の䜜成は、吞匕濟過し
た゚ポキシ基を有する担䜓に、該担䜓圓り、
アルカリ氎溶液PH11〜13を〜50ml添加した
埌、玚氎酞基ず過ペり玠酞酞化による開裂可胜
なゞオヌル基を有する単糖たたは糖を添加し、
20℃〜40℃で振盪する。反応時間は〜30時間が
奜たしい。 添加する単糖たたは糖ぱポキシ基〔゚ポキ
シ基の量はL.SundbergらJ.Chromatogr.第90
巻、87〜98頁、1974幎の方法により枬定〕のモ
ル数に察しお10〜50倍が奜たしい。 生成した単糖たたは糖結合䞍溶性高分子担䜓
においお単糖たたは糖ぱポキシ基ず䞀番反応
性の高い第アルコヌルの氎酞基を介しお結合さ
れる。 本発明方法においお䜿甚する玚氎酞基ず過ペ
り玠酞酞化により開裂可胜なゞオヌル基ずを有す
る単糖ずしおは、グルコヌス、マンノヌス、ガラ
クトヌス、タロヌス等のアルドヘキ゜ヌス、−
アセチルグルコサミン、−アセチルガラクトサ
ミン等のアミノ糖等があり、たた、玚氎酞基ず
過ペり玠酞酞化により開裂可胜なゞオヌル基ずを
有する糖ずしおは、ラクトヌス、マルトヌス、
シペ糖等がある。 単糖たたは糖結合䞍溶性高分子担䜓の酞化開
裂は、過ペり玠酞たたはその塩、奜たしくは0.04
〜0.2N過ペり玠酞ナトリりム氎溶液を吞匕濟過
した糖たたは糖結合䞍溶性高分子担䜓に、該担
䜓圓り〜100ml添加し、℃〜20℃、30分
〜時間ずいう範囲内で反応させお行うこずが奜
たしい。 玚氎酞基ず過ペり玠酞酞化により開裂可胜な
ゞオヌル基を有する単糖ずしお、グルコヌスを甚
いた堎合は䞻に構造匏〔〕のスペヌサヌが導入
される。 匏䞭、は䞍溶性高分子担䜓を瀺し、〜〜は
過ペり玠酞ナトリりムにより酞化開裂する個所を
瀺す。以䞋の匏も同様である。 他に構造匏〔〕〔〕〔〕〔〕のスペヌサ
ヌが導入されるが、いずれのスペヌサヌもアルデ
ヒド基を有し、生理掻性物質を固定化する堎合有
効ずなる。 玚氎酞基ず過ペり玠酞酞化により開裂可胜な
ゞオヌル基を有する糖ずしお、ラクトヌスを甚
いた堎合は䞻に構造匏〔〕、〔〕のスペヌサヌ
が導入される。 他にグルコヌスの堎合ず同様、数皮のアルデヒ
ド基を有するスペヌサヌず酞化開裂されない糖を
有するスペヌサヌが導入される。アルデヒド基を
有するスペヌサヌは生理掻性物質を固定化する堎
合有効であり、たた、糖を有するスペヌサヌは安
定であり、アフむニテむヌクロマトグラフむヌに
おいお䜕ら劚げずならない。 䞊蚘反応により埗られたアルデヒド掻性化䞍溶
性高分子担䜓ずタンパン質、ペプチド、アミノ
酞、および生䜓アミン等アミノ基を有する生理掻
性物質を反応させお固定化するこずにより、固定
化生理掻性物質を埗るこずができる。 アミノ基を有する生理掻性物質の䟋ずしおは、
レクチン、りシ血枅アルブミン、γ−グロプリン
抗䜓、酵玠、フむプロネクチン、プロテむン
等のタンパク質、色玠タンパク質、糖タンパク
質、リンタンパク質等の耇合タンパク質、キニ
ン、副腎皮質刺激ホルモン攟出因子CRF、カ
ルシトニン、グルカゎン等のプペチド、皮々のア
ミノ酞、およびヒスタミン、ドヌバ、トリブタミ
ン等の生䜓アミン等がある。 この時甚いる溶媒ずしおは、リン酞緩衝液、酢
酞緩衝液等の緩衝液を䜿甚し、固定化される生理
掻性物質の掻性がPH䟝存性の堎合は適応するPH
で、䞀般の堎合はPH〜PH10の範囲内で反応を行
う方法が奜たしい。 生理掻性物質を溶解した緩衝液の量は、吞匕濟
過したアルデヒド掻性化䞍溶性高分子担䜓圓
りml〜10mlの範囲内にあるこずが奜たしい。 反応枩床は固定化する生理掻性物質の掻性安定
領域で行う。奜たしくは℃〜40℃で行う。 反応時間は固定化反応途䞭の残存生理掻性物質
量を枬定するこずにより決定されるが、通垞時
間〜72時間で十分である。 䞊蚘反応埌、シアノホり玠化氎玠ナトリりムた
たはホり玠化氎玠ナトリりムを添加し、生成した
シツフ塩基を還元し安定化する。 還元剀に察しお䞍安定な生理掻性物質の堎合
は、シアノホり玠化氎玠ナトリりムを䜿甚する方
が奜たしい。 還元剀の量は吞匕濟過担䜓圓り30mg以䞊あ
れば十分であり、還元反応は℃〜40℃の範囲内
で〜24時間反応すれば十分である。 埗られた生理掻性物質固定化䞍溶性高分子担䜓
にシアノホり玠化ナトリりムを吞匕濟過担䜓
圓り30mg以䞊含む任意量の0.5〜2Mトリス−塩酞
緩衝液PH7.4を入れ、℃〜40℃の範囲内で
30分〜時間攟眮する。これにより担䜓に残存す
るアルデヒド基を䞍掻性基ぞず導びくこずができ
る。 以䞊の反応によ぀お高濃床のリガンド導入が可
胜ずなり、たた、過ペり玠酞の反応条件を倉曎さ
せるこずにより、たたはリガンドずなる生理掻性
物質の量を倉曎させるこずにより、自由にそのリ
ガンド濃床を倉曎するこずができる。固定化収率
も玄90ずすぐれおいる。 〔発明の効果〕 本発明方法によれば、埓来の生理掻性物質の固
定化法の欠点を倧幅に改良するこずができる。す
なわち、スペヌサヌに関しおは、電荷を持た
ず、非特異的吞着が少ない、導入されたスペヌ
サヌは化孊的に安定であり、臭化シアン法にみら
れるリガンドの挏出が少ない、芪氎性のスペン
サヌを有する、等の特長がある。 たた、リガンドに関しおは、高いリガンド濃
床が埗られ、か぀、、リガンド量は自由に倉曎で
きる、リガンドの反応収率が非垞に高い、等の
特長がある。 その他に、゚ポキシ基の導入により、架橋が
圢成され、担䜓が匷化されおいる、担䜓に糖を
結合した状態で長期保存ができ、固定化反応を行
う盎前、過ペり玠酞酞酞化を行い、固定化に䟛す
るこずができる、ずいう特長も有する。 〔実斜䟋〕 次に本発明の実斜䟋を瀺し、本発明をさらに説
明する。 実斜䟋  (1)グルコヌス固定化アガロヌスの調補 アガロヌスゲルずしおフマルマシア瀟セフア
ロヌス4Bを甚いた。 グラスフむルタヌ䞊で、氎で十分に掗浄埌、゚
ポキシ化は吞匕濟過したアガロヌスゲル30に50
ゞメチルスルホキシド45ml、2M NaOH20ml、
゚ピクロルヒドリン4.5mlを添加し、40℃で時
間振盪した。反応埌、グラスフむルタヌに移し、
氎で十分に掗浄しお゚ポキシ掻性化セフアロヌス
4Bを埗た。導入された゚ポキシ基はNa2S2O3を
䜿甚するL.Sundbengらの方法により枬定したず
ころ、吞匕濟過セフアロヌス4B1圓り玄
40ÎŒmolの゚ポキシ基が導入された。 この゚ポキシ掻性化アガロヌスゲル20にグル
コヌスを溶解した80mlの0.1N NaOH溶液を
添加し、37℃で20時間振盪した。反応埌、グラス
フむルタヌ䞊で、氎で十分掗浄し、グルコヌス結
合アガロヌスを埗た。 (2) レクチンの固定化 グルコヌス固定化アガロヌス15に0.1N過ペ
り玠酞ナトリりム氎溶液150mlを加え、℃で
時間振盪した。反応埌、グラスフむルタヌに移
し、酞性氎溶液PHで十分に掗浄埌さらに氎
で十分に掗浄し、アルデヒド掻性化アガロヌスを
埗た。 アルデヒド掻性化アガロヌスに察し、コン
カナバリン以䞋「ConA」ずいう、0.2Mα−
メチルマンノシドを含む0.1M酢緩衝液PH6.0
10mlを添加した。ConA量は58mg、110mg、156
mg、236mg、ず倉え、℃で48時間振盪した。 反応埌、各条件のものにシアノホり玠化氎玠ナ
トリりムを100mg添加し、さらに、℃で12時間
振盪した。 反応物をグラスフむルタヌに移し、0.1M酢酞
緩衝液PH6.0で十分に掗浄し、ConA−アガロ
ヌスをを埗た。 埗られたConA−アガロヌスにシアノホり
玠化氎玠ナトリりム100mgを含む1Mトリス−塩酞
緩衝液PH7.415mlを加え、宀枩で時間攟眮
埌、グラスフむルタヌ䞊で、氎で十分に掗浄し
た。 固定化量はもずのConAの280nmの吞光床ず残
存しおいたConAの280nmの吞光床の差より固定
化量ずした。その結果を衚に瀺す。
[Industrial Application Field] The present invention is a bioactive substance that is stable, has little nonspecific adsorption, has a hydrophilic spacer, and has a high concentration of ligand (a substance that has affinity with the target substance). Regarding manufacturing methods. As a ligand, it is applicable to all physiologically active substances having an amino group, such as proteins, peptides, amino acids, and biogenic amines. [Prior Art] Conventionally, as a polymer carrier for immobilization used to produce an immobilized physiologically active substance, one that does not have non-specific adsorption and has a functional group that can be activated is considered suitable. . In particular, when used as an affinity adsorbent, the adsorption capacity can be increased due to the porosity, and the physical
A chemically stable, spherical polymeric carrier is preferred. Agarose gel, polyvinyl alcohol resin, and the like have been put into practical use as such polymer carriers. [Problems to be solved by the invention] There is a method of using cyanogen bromide as an immobilization method using covalent bonds [Nature, Vol. 215, 1491~
1492 pages (1967)]. This method is widely used for immobilizing amino groups and phosphate groups because the reaction steps are short and it can be easily prepared. In this case, the isourea bond forming the crosslinking part is unstable, and if the buffer used for affinity chromatography becomes alkaline, there is a risk that the immobilized ligand will leak out. is about 10, so it has a positive charge near neutrality, so it has the disadvantage of non-specific adsorption. Periodate oxidation of polysaccharides is a method for immobilizing substances with amino groups [Immunology, Vol. 20, pp. 1061-1065 (1971
Year)〕. This involves oxidizing the diol structure of the constituent sugar residues of polysaccharides with periodate, reacting the aldehyde group generated by oxidative cleavage with an amino group, and further reducing it with sodium borohydride to create an insoluble immobilized substance. It's a method. However, this method has decisive deficiencies as an affinity adsorbent in that a spacer (a molecule of arbitrary length to be introduced between the ligand and the carrier) cannot be introduced and the concentration of the ligand is low. [Means for Solving the Problems] The present invention significantly improves the drawbacks of the aforementioned cyanogen bromide method, polysaccharide periodate oxidation method, etc.
An insoluble polymer carrier having an epoxy group or a hydroxyl group introduced with a spacer having an epoxy group,
An insoluble polymer carrier having an amino group, a carboxyl group, or/and an amide group is reacted under alkaline conditions with a monosaccharide or disaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation. A physiologically active substance having an amino group is reacted with an aldehyde group generated by oxidative cleavage of a sugar-bonded insoluble polymer with periodic acid,
A Schiff base is formed between the two for immobilization, and if necessary, the bond is stabilized by reducing this reactant with commonly used sodium borohydride or sodium cyanoborohydride. It is. The insoluble polymer having an epoxy group used in the method of the present invention may be any water-insoluble and stable polymer that already has an epoxy group or into which an epoxy group has been introduced through a chemical reaction. Examples of insoluble polymer carriers having epoxy groups include polyglycidyl methacrylate or copolymers thereof, epoxy resins, etc. When these carriers are used, they are subjected to the reaction as they are. Examples of insoluble polymeric carriers having hydroxyl groups include agarose, polyvinyl alcohol resin, hydroxyethyl (or methyl) acrylate or its copolymer, hydroxyethyl (or methyl) methacrylate or its copolymer, N-methylol Examples of insoluble polymer carriers having amino groups include aminoethyl agarose, aminohexyl agarose, aminoethyl polyacrylamide, etc. Examples of insoluble polymer carriers having carboxyl groups include acrylamide or its copolymers, etc. There are polymers of maleic acid or copolymers thereof, polymers of acrylic acid or copolymers thereof, polymers of methacrylic acid or copolymers thereof, polymers of itaconic acid or copolymers thereof, etc., which are insoluble and have an amide group. Examples of polymeric carriers include polyacrylamide-based polymers, but when using these carriers, epoxy groups are introduced using epihalohydrin or bisoxirane compounds such as epichlorohydrin and epibromohydrin by known methods. After that, it is necessary to subject it to a reaction. To create a sugar-bonded insoluble polymer carrier, per 1 g of the carrier,
After adding 3 to 50 ml of an alkaline aqueous solution (PH 11 to 13), add a monosaccharide or disaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation,
Shake at 20°C to 40°C. The reaction time is preferably 5 to 30 hours. The monosaccharide or disaccharide to be added has an epoxy group [the amount of epoxy group is determined according to L. Sundberg et al. (J. Chromatogr., No. 90).
Vol. 87-98, 1974). In the produced monosaccharide- or disaccharide-bound insoluble polymer carrier, the monosaccharide or disaccharide is bound via the hydroxyl group of the primary alcohol, which is most reactive with the epoxy group. Monosaccharides having a primary hydroxyl group and a diol group cleavable by periodic acid oxidation used in the method of the present invention include aldohexoses such as glucose, mannose, galactose, and talose, N-
There are amino sugars such as acetylglucosamine and N-acetylgalactosamine, and disaccharides having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation include lactose, maltose,
There are sugar, etc. Oxidative cleavage of monosaccharide- or disaccharide-bound insoluble polymeric carriers is performed using periodic acid or its salts, preferably 0.04
Add 3 to 100 ml of ~0.2N sodium periodate aqueous solution per 1 g of the sugar- or disaccharide-bonded insoluble polymer carrier that has been suction-filtered, and react at 0°C to 20°C for 30 minutes to 5 hours. It is preferable to do so. When glucose is used as the monosaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation, a spacer of structural formula [1] is mainly introduced. (In the formula, G represents an insoluble polymer carrier, and ~ ~ represents a site that is oxidized and cleaved by sodium periodate. The same applies to the following formulas.) Other structural formulas [2] [3] [4] The spacer [5] is introduced, and all of the spacers have an aldehyde group and are effective when immobilizing a physiologically active substance. When lactose is used as a disaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation, spacers of structural formulas [6] and [7] are mainly introduced. In addition, as in the case of glucose, spacers with several types of aldehyde groups and spacers with sugars that are not oxidatively cleaved are introduced. A spacer having an aldehyde group is effective for immobilizing a physiologically active substance, and a spacer having a sugar is stable and does not interfere with affinity chromatography. Obtaining an immobilized physiologically active substance by reacting and immobilizing the aldehyde-activated insoluble polymer carrier obtained by the above reaction with a physiologically active substance having an amino group such as proteins, peptides, amino acids, and biogenic amines. I can do it. Examples of physiologically active substances having an amino group include:
Lectin, bovine serum albumin, γ-globulin (antibody), enzyme, fipronectin, protein A
complex proteins such as chromoproteins, glycoproteins, phosphoproteins, kinins, pupetides such as corticotropin-releasing factor (CRF), calcitonin, and glucagon, various amino acids, and biogenic amines such as histamine, dova, and tributamine. etc. The solvent used at this time is a buffer such as phosphate buffer or acetate buffer, and if the activity of the physiologically active substance to be immobilized is pH-dependent, the appropriate pH is used.
In general, it is preferable to carry out the reaction within the range of PH5 to PH10. The amount of the buffer solution in which the physiologically active substance is dissolved is preferably within the range of 2 ml to 10 ml per gram of the suction-filtered aldehyde-activated insoluble polymer carrier. The reaction temperature is set at a stable activity range of the physiologically active substance to be immobilized. Preferably it is carried out at 0°C to 40°C. The reaction time is determined by measuring the amount of physiologically active substance remaining during the immobilization reaction, and usually 5 to 72 hours is sufficient. After the above reaction, sodium cyanoborohydride or sodium borohydride is added to reduce and stabilize the generated Schiff base. In the case of physiologically active substances that are unstable to reducing agents, it is preferable to use sodium cyanoborohydride. It is sufficient that the amount of the reducing agent is 30 mg or more per gram of the suction filtration carrier, and it is sufficient that the reduction reaction is carried out at a temperature of 0°C to 40°C for 2 to 24 hours. Suction 1 g of sodium cyanoboride onto the obtained physiologically active substance-immobilized insoluble polymer carrier.
Add any amount of 0.5 to 2M Tris-HCl buffer (PH7.4) containing 30mg or more per bottle, and store at 0℃ to 40℃.
Leave it for 30 minutes to 2 hours. This allows the aldehyde groups remaining on the carrier to become inert groups. The above reaction makes it possible to introduce a high concentration of the ligand, and by changing the reaction conditions of periodic acid or by changing the amount of the physiologically active substance serving as the ligand, the concentration of the ligand can be adjusted freely. Can be changed. The immobilization yield is also excellent at approximately 90%. [Effects of the Invention] According to the method of the present invention, the drawbacks of conventional methods for immobilizing physiologically active substances can be significantly improved. That is, regarding the spacer, it has no electric charge, has little non-specific adsorption, is chemically stable, has a hydrophilic spacer that causes less leakage of the ligand seen in the cyanogen bromide method, It has the following features. Further, regarding the ligand, there are advantages such as a high concentration of the ligand can be obtained, the amount of the ligand can be changed freely, and the reaction yield of the ligand is very high. In addition, by introducing epoxy groups, crosslinks are formed and the carrier is strengthened. It can be stored for a long time with sugar bound to the carrier. Immediately before the immobilization reaction, periodic acid oxidation is performed to immobilize It also has the advantage of being able to be used for various purposes. [Example] Next, Examples of the present invention will be shown to further explain the present invention. Example 1 (1) Preparation of glucose-immobilized agarose Fumarmacia Sepharose 4B was used as the agarose gel. After thoroughly washing with water on a glass filter, epoxidation was performed by adding 50 g of suction-filtered agarose gel.
% dimethyl sulfoxide 45ml, 2M NaOH20ml,
4.5 ml of epichlorohydrin was added and the mixture was shaken at 40°C for 2 hours. After the reaction, transfer to a glass filter,
Epoxy-activated Cephalose by washing thoroughly with water.
Got 4B. The introduced epoxy group was measured by the method of L. Sundbeng et al. using Na 2 S 2 O 3 and was found to be approximately
40 Όmol of epoxy groups were introduced. To 20 g of this epoxy-activated agarose gel was added 80 ml of a 0.1N NaOH solution in which 3 g of glucose was dissolved, and the mixture was shaken at 37° C. for 20 hours. After the reaction, the mixture was thoroughly washed with water on a glass filter to obtain glucose-bonded agarose. (2) Immobilization of lectin Add 150 ml of 0.1N sodium periodate aqueous solution to 15 g of glucose-immobilized agarose, and
Shake for hours. After the reaction, the mixture was transferred to a glass filter, thoroughly washed with an acidic aqueous solution (PH3), and then thoroughly washed with water to obtain aldehyde-activated agarose. Concanavalin A (hereinafter referred to as "ConA"), 0.2M α-
0.1M vinegar buffer containing methylmannoside (PH6.0)
Added 10ml. ConA amount is 58mg, 110mg, 156
mg, 236 mg, and shaken at 4°C for 48 hours. After the reaction, 100 mg of sodium cyanoborohydride was added to each condition, and the mixture was further shaken at 4°C for 12 hours. The reaction mixture was transferred to a glass filter and thoroughly washed with 0.1M acetate buffer (PH6.0) to obtain ConA-agarose. 15 ml of 1M Tris-HCl buffer (PH7.4) containing 100 mg of sodium cyanoborohydride was added to 3 g of the obtained ConA-agarose, and after being left at room temperature for 1 hour, it was thoroughly washed with water on a glass filter. The amount of immobilization was determined from the difference between the absorbance of the original ConA at 280 nm and the absorbance of the remaining ConA at 280 nm. The results are shown in Table 1.

【衚】 固定化量はConAで瀺した通り、反応に䜿甚する
レクチン量を倉曎すれば、それに応じお固定化量
の倉曎が可胜ある。 埗られた固定化ConA−アガロヌスに぀いお固
定化されたConAず盞互䜜甚を有するパラアミノ
プニルマンノシドを甚いお吞着容量を前端分析
により怜定した。 ゲルはml〔カラム盎埄mm×長さcm〕
を䜿甚し、察照ずしおConAず盞互䜜甚を有しな
いパラアミノプニルガラクトシドを䜿甚した。
その結果を衚に瀺す。
[Table] As shown in ConA, by changing the amount of lectin used in the reaction, the amount of immobilization can be changed accordingly. The adsorption capacity of the obtained immobilized ConA-agarose was tested by front-end analysis using para-aminophenyl mannoside that interacts with immobilized ConA. 1 ml of gel [column (diameter 4 mm x length 8 cm)]
was used, and para-aminophenyl galactoside, which has no interaction with ConA, was used as a control.
The results are shown in Table 2.

【衚】 さらに、ハむマンノヌスタむプの糖鎖を有する
倧豆レクチン以䞋「SBA」ずいうを甚いお
吞着量を怜定した。ConA−アガロヌスml18
mgConAmlゲル圓りSBAが34mg吞着された。 固定化ConAアガロヌスは十分な吞着胜力を有
し、くりかえし䜿甚によ぀おも吞着胜の䜎䞋は芋
られなか぀た。 実斜䟋  (1) ラクトヌス固定化アガロヌスの調補 アガロヌスゲルずしおフアルマシア瀟セフアロ
ヌス4Bを甚いた。 グラスフむルタヌ䞊で、氎で十分に掗浄埌、゚
ポキシ化は吞匕濟過したアガロヌスゲル30に50
ゞメチルスルホキシド45ml、2M NaOH20ml、
゚ピクロルヒドリン4.5mlを添加し、40℃で時
間振盪した。反応埌、グラスフむルタヌに移し、
氎で十分に掗浄しお゚ポキシ掻性化セフアロヌス
4Bを埗た。導入された゚ポキシ基はNa2S2O3を
䜿甚するL.Sundbengらの方法により枬定した。
吞匕濟過セフアロヌス4B1圓り玄40ÎŒmolの゚
ポキシ基が導入された。 この゚ポキシ掻性化アガロヌスゲル20にラク
トヌスを溶解した80mlの0.1N NaOH溶液を
添加し、37℃で20時間振盪した。反応埌、グラス
フむルタヌ䞊で、氎で十分掗浄し、ラクトヌス結
合アガロヌスを埗た。 (2)牛血枅アルブミン以䞋「BSA」ずいうの
固定化 ラクトヌス固定化アガロヌス15に0.1N過ペ
り玠酞ナトリりム氎溶液150mlを加え、℃で
時間振盪した。反応埌、、グラスフむルタヌに移
し、酞性氎溶液PHで十分に掗浄埌、さらに
氎で十分に掗浄し、アルデヒド掻性化アガロヌス
を埗た。 アルデヒド掻性化アガロヌスにBSA250mg
を溶解した0.1Mリン酞緩衝液PH7.210mlを加
え、25℃で24時間振盪した。その埌、ホり玠化氎
玠ナトリりム90mgを加え、時間振盪した。反応
終了埌、䞊枅を陀き0.1Mリン酞緩衝液で十分に
掗浄し、固定化BSAアガロヌスを埗た。固定化
量はConAず同様280nmの吞光床の差より求め
た。 その結果を実斜䟋の固定化ConAず䜵せお衚
に瀺す。 なお、参考たでに、アガロヌスを盎接過ペり玠
酞酞化する埓来法〔Methods in Enzymology、
38巻、PartB、82頁、1974〕によるアルブミン
の固定化量を䜵蚘した。
[Table] Furthermore, the amount of adsorption was assayed using soybean lectin (hereinafter referred to as "SBA") having a high mannose type sugar chain. ConA-Agarose 1 ml (18
34mg of SBA was adsorbed per mgConA/ml gel). The immobilized ConA agarose had sufficient adsorption capacity, and no decrease in adsorption capacity was observed even after repeated use. Example 2 (1) Preparation of lactose-immobilized agarose Sepharose 4B manufactured by Pharmacia Co., Ltd. was used as the agarose gel. After thoroughly washing with water on a glass filter, epoxidation was performed by adding 50 g of suction-filtered agarose gel.
% dimethyl sulfoxide 45ml, 2M NaOH20ml,
4.5 ml of epichlorohydrin was added and the mixture was shaken at 40°C for 2 hours. After the reaction, transfer to a glass filter,
Epoxy-activated Cephalose by washing thoroughly with water.
Got 4B. The introduced epoxy group was measured by the method of L. Sundbeng et al. using Na 2 S 2 O 3 .
Approximately 40 Όmol of epoxy groups were introduced per gram of suction-filtered Sepharose 4B. 80 ml of a 0.1N NaOH solution containing 6 g of lactose was added to 20 g of this epoxy-activated agarose gel, and the mixture was shaken at 37° C. for 20 hours. After the reaction, the mixture was thoroughly washed with water on a glass filter to obtain lactose-bonded agarose. (2) Immobilization of bovine serum albumin (hereinafter referred to as "BSA") Add 150 ml of 0.1N sodium periodate aqueous solution to 15 g of lactose-immobilized agarose, and
Shake for an hour. After the reaction, the mixture was transferred to a glass filter, thoroughly washed with an acidic aqueous solution (PH3), and then thoroughly washed with water to obtain aldehyde-activated agarose. 3g of aldehyde-activated agarose and 250mg of BSA
10 ml of 0.1M phosphate buffer (PH7.2) in which 20% was dissolved was added, and the mixture was shaken at 25°C for 24 hours. Thereafter, 90 mg of sodium borohydride was added and the mixture was shaken for 1 hour. After the reaction was completed, the supernatant was removed and thoroughly washed with 0.1M phosphate buffer to obtain immobilized BSA agarose. The amount of immobilization was determined from the difference in absorbance at 280 nm, similar to ConA. The results are shown in Table 3 together with the immobilized ConA of Example 1. For reference, the conventional method of directly oxidizing agarose with periodate [Methods in Enzymology,
38, Part B, p. 82, 1974)] is also shown.

【衚】【table】

Claims (1)

【特蚱請求の範囲】[Claims]  ゚ポキシ基を有する䞍溶性高分子を、アルカ
リ性の条件䞋で、玚氎酞基ず過ペり玠酞酞化に
より開裂可胜なゞオヌル基ずを有する単糖たたは
糖ず反応させ、埗られた糖結合䞍溶䜓高分子を
過ペり玠酞にお酞化開裂するこずにより生じるア
ルデヒド基に、アミノ基を有する生理掻性物質を
反応させお固定化し、さらに芁すれば、この反応
物を氎玠化ホり玠ナトリりムやシアノ氎玠化ホり
玠ナトリりムで還元しお結合を安定化するこずを
特城ずする固定化生理掻性物質の補造法。
1. A sugar-bonded insoluble polymer obtained by reacting an insoluble polymer having an epoxy group with a monosaccharide or disaccharide having a primary hydroxyl group and a diol group that can be cleaved by periodic acid oxidation under alkaline conditions. A physiologically active substance having an amino group is reacted with the aldehyde group produced by the oxidative cleavage of the compound with periodic acid to immobilize it, and if necessary, this reactant is treated with sodium borohydride or sodium cyanoborohydride. A method for producing an immobilized physiologically active substance, characterized by stabilizing the bond by reduction.
JP59280689A 1984-12-27 1984-12-27 Production of immobilized physiologically active substance Granted JPS61152634A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59280689A JPS61152634A (en) 1984-12-27 1984-12-27 Production of immobilized physiologically active substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59280689A JPS61152634A (en) 1984-12-27 1984-12-27 Production of immobilized physiologically active substance

Publications (2)

Publication Number Publication Date
JPS61152634A JPS61152634A (en) 1986-07-11
JPH0456807B2 true JPH0456807B2 (en) 1992-09-09

Family

ID=17628566

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59280689A Granted JPS61152634A (en) 1984-12-27 1984-12-27 Production of immobilized physiologically active substance

Country Status (1)

Country Link
JP (1) JPS61152634A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62155300A (en) * 1985-12-27 1987-07-10 Sugiyama Sangyo Kagaku Kenkyusho Production of immobilized physiologically active substance
DE69225542T2 (en) * 1991-02-21 1998-09-10 Drug Delivery System Inst Ltd CARBOXYMETHYLMANNOGLUKAN AND DERIVATIVES THEREOF

Also Published As

Publication number Publication date
JPS61152634A (en) 1986-07-11

Similar Documents

Publication Publication Date Title
US3645852A (en) Method of binding water-soluble proteins and water-soluble peptides to water-insoluble polymers using cyanogen halide
US5092992A (en) Polyethyleneimine matrixes for affinity chromatography
US6699386B2 (en) Endotoxin adsorbent, and a method of removing endotoxin by using the same
JPS6159175B2 (en)
JPH037681B2 (en)
US5085779A (en) Polyethyleneimine matrixes for affinity chromatography
JPS61272202A (en) Production of material for affinity chromatography
JPH051714B2 (en)
JP2002119854A (en) Separating material for stimulus response type affinity chromatography material and separating and refining method
EP0431220A1 (en) Method of making a sulfonate ester and cross-linked alcohol coated support matrix
JPS6133557B2 (en)
JPS5853757A (en) Adsorbent for immuno-affinity chromatography and manufacture of same
EP0153763B1 (en) Affinity chromatography matrix with built-in reaction indicator
JPH0456807B2 (en)
DE2102514A1 (en) Process for the chemical coupling of biologically active substances to polymers containing oxirane
Scouten Matrices and activation methods for cell adhesion/immobilization studies
EP0403700B1 (en) Polyethyleneimine matrixes for affinity chromatography
CN102580683B (en) Endotoxin synergistic adsorbent and preparation method thereof
US4775714A (en) Method for producing highly-active biologically active compounds immobilized on a carrier
JPS59204601A (en) Manufacture of molded article having physiological activity
JPS62155300A (en) Production of immobilized physiologically active substance
JPH05261281A (en) Carrier for immobilizing bioactive substance and its production
JPH0518950A (en) Attraction carrier for affinity chromatography
JPH0359080B2 (en)
JPS60202737A (en) Manufacture of affinity adsorbent

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees